Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease
Key facts
- Who runs it
- Tor Biering-Sørensen
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 299,881 people enrolled
- Started
- 24 Sept 2023
- Ended
- 31 May 2024
- Type of study
- Interventional, 7 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Behavioral Economic Principles
- Record updated
- 10 October 2024
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Age 18-64 years
- Must be registered in the Danish nationwide registries as meeting at least one of the following eligibility criteria for free-of-charge influenza vaccination in the Danish public health system:; Chronic lung disease; Chronic cardiovascular disease other than hypertension; Type 1 or type 2 diabetes mellitus; Congenital or acquired immunodeficiency; Impaired breathing due to muscular weakness; Chronic renal or hepatic insufficiency; Other chronic conditions with an increased risk of severe influenza as determined by the treating physician
- Access to the official, mandatory Danish electronic mailbox system
Who cannot take part
- None
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In randomized clinical trials and observational studies, influenza vaccination has been shown to be effective in reducing influenza-related illness, hospitalizations, cardiovascular events, and mortality in select populations. However, the real-world effectiveness of influenza vaccination is limited by its uptake. This study will investigate whether digital behavioral nudges delivered via the official, mandatory Danish electronic letter system can increase influenza vaccine uptake among adults aged 18-64 years with chronic diseases.
The 7 groups in the trial
- Usual CareNo study treatment, for comparison
No letter
- Standard LetterTreatment being tested
This group will receive a standard letter on the benefits of influenza vaccination without behavioral economic enhancement
Treatment: Behavioral Economic Principles
- Repeated LetterTreatment being tested
The standard letter sent out two times instead of once
Treatment: Behavioral Economic Principles
- Cardiovascular Gain-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential cardiovascular benefits of influenza vaccination
Treatment: Behavioral Economic Principles
- Respiratory Gain-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential respiratory disease-related benefits of influenza vaccination
Treatment: Behavioral Economic Principles
- Implementation Intention Prompt LetterTreatment being tested
Implementation intention prompt added to the standard letter
Treatment: Behavioral Economic Principles
- Loss-Framing LetterTreatment being tested
Text added to the standard letter highlighting potential risks of not receiving influenza vaccination
Treatment: Behavioral Economic Principles
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Electronic Nudges to Increase Influenza Vaccination in Immunosuppressed Adults Across the Age Spectrum: A Pooled Analysis of 2 Nationwide Randomized Trials.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2026
- Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical Trials.JAMA cardiology, 2025
- Electronic Nudges to Increase Influenza Vaccination in Patients With Chronic Diseases: A Randomized Clinical Trial.JAMA, 2024
- Electronic Nudge Letters to Increase Influenza Vaccination Uptake in Younger and Middle-Aged Individuals With Diabetes.JACC. Advances, 2024
- Rationale and design of NUDGE-FLU-CHRONIC and NUDGE-FLU-2: Two nationwide randomized trials of electronic nudges to increase influenza vaccination among patients with chronic diseases and older adults during the 2023/2024 influenza season.American heart journal, 2024
- Record updated
- 10 October 2024